|
US20040171062A1
(en)
|
2002-02-28 |
2004-09-02 |
Plexxikon, Inc. |
Methods for the design of molecular scaffolds and ligands
|
|
CA2503905A1
(en)
|
2002-09-16 |
2004-03-25 |
Plexxikon, Inc. |
Crystal structure of pim-1 kinase
|
|
US20050048573A1
(en)
|
2003-02-03 |
2005-03-03 |
Plexxikon, Inc. |
PDE5A crystal structure and uses
|
|
JP2007524374A
(ja)
|
2003-02-28 |
2007-08-30 |
プレキシコン，インコーポレーテッド |
Ｐｙｋ２結晶構造および使用
|
|
US20050079548A1
(en)
|
2003-07-07 |
2005-04-14 |
Plexxikon, Inc. |
Ligand development using PDE4B crystal structures
|
|
KR101415503B1
(ko)
|
2003-07-17 |
2014-07-04 |
플렉시콘, 인코퍼레이티드 |
Ｐｐａｒ 활성 화합물
|
|
US7348338B2
(en)
|
2003-07-17 |
2008-03-25 |
Plexxikon, Inc. |
PPAR active compounds
|
|
WO2005028624A2
(en)
|
2003-09-15 |
2005-03-31 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
|
US7517970B2
(en)
|
2003-12-19 |
2009-04-14 |
Plexxikon, Inc. |
Nucleic acids encoding kinase and phosphatase enzymes, expression vectors and cells containing same
|
|
PL1696920T3
(pl)
|
2003-12-19 |
2015-03-31 |
Plexxikon Inc |
Związki i sposoby opracowywania modulatorów Ret
|
|
US20070066641A1
(en)
|
2003-12-19 |
2007-03-22 |
Prabha Ibrahim |
Compounds and methods for development of RET modulators
|
|
JP2008503446A
(ja)
|
2004-05-06 |
2008-02-07 |
プレキシコン，インコーポレーテッド |
Ｐｄｅ４ｂ阻害剤及びその使用
|
|
US7498342B2
(en)
|
2004-06-17 |
2009-03-03 |
Plexxikon, Inc. |
Compounds modulating c-kit activity
|
|
JP2008503473A
(ja)
|
2004-06-17 |
2008-02-07 |
プレキシコン，インコーポレーテッド |
Ｃ−ｋｉｔ活性を調節する化合物
|
|
EP1786813A2
(en)
|
2004-09-03 |
2007-05-23 |
Plexxikon, Inc. |
Bicyclic heteroaryl pde4b inhibitors
|
|
JP2008521831A
(ja)
|
2004-11-30 |
2008-06-26 |
プレキシコン，インコーポレーテッド |
Ｐｐａｒ活性化合物
|
|
US7531568B2
(en)
|
2004-11-30 |
2009-05-12 |
Plexxikon, Inc. |
PPAR active compounds
|
|
US20060160135A1
(en)
|
2004-12-08 |
2006-07-20 |
Weiru Wang |
SF-1 and LRH-1 modulator development
|
|
CA2608733A1
(en)
|
2005-05-17 |
2007-02-01 |
Plexxikon, Inc. |
Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
|
|
DK2395004T3
(en)
|
2005-06-22 |
2016-03-21 |
Plexxikon Inc |
Pyrrolo [2,3-b] pyridine derivatives as protein kinase inhibitors
|
|
AU2006287528A1
(en)
|
2005-09-07 |
2007-03-15 |
Plexxikon, Inc. |
1 , 4 and 1 , 5-disubstituted indole derivatives for use as PPAR active compounds
|
|
AU2006287513A1
(en)
|
2005-09-07 |
2007-03-15 |
Plexxikon, Inc. |
1, 3-disubstituted indole derivatives for use as PPAR modulators
|
|
EP1940767A2
(en)
|
2005-09-07 |
2008-07-09 |
Plexxikon, Inc. |
Pparactive compounds
|
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
|
WO2008080015A2
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
PE20081581A1
(es)
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
PE20090159A1
(es)
|
2007-03-08 |
2009-02-21 |
Plexxikon Inc |
COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
|
|
JP2010520303A
(ja)
|
2007-03-08 |
2010-06-10 |
プレキシコン，インコーポレーテッド |
Ｐｐａｒ活性化合物
|
|
US20100190777A1
(en)
|
2007-07-17 |
2010-07-29 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
US8158636B2
(en)
|
2008-05-19 |
2012-04-17 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
|
US8119637B2
(en)
|
2008-06-10 |
2012-02-21 |
Plexxikon Inc. |
Substituted pyrrolo[2,3-b]pyrazines and methods for kinase modulation, and indications therefor
|
|
US8110576B2
(en)
|
2008-06-10 |
2012-02-07 |
Plexxikon Inc. |
Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications
|
|
EP2406260A1
(en)
|
2009-03-11 |
2012-01-18 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b]pyridine derivatives for the inhibition of raf kinases
|
|
TW201036973A
(en)
|
2009-03-11 |
2010-10-16 |
Plexxikon Inc |
Compounds and uses thereof
|
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
|
HUE027598T2
(en)
|
2009-04-03 |
2016-10-28 |
Hoffmann La Roche |
Propane-1-sulfonic acid {3- [5- (4-chlorophenyl) -1H-pyrrolo [2,3-B] pyridine-3-carbonyl] -2,4-difluorophenyl} amide compositions and their uses
|
|
MX2011011735A
(es)
|
2009-05-04 |
2011-11-29 |
Plexxikon Inc |
Compuestos y metodos para la inhibicion de renina, e indicaciones para ello.
|
|
TW201041888A
(en)
|
2009-05-06 |
2010-12-01 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
ES2633317T3
(es)
|
2009-11-06 |
2017-09-20 |
Plexxikon, Inc. |
Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
|
|
JP2013511541A
(ja)
|
2009-11-18 |
2013-04-04 |
プレキシコン インコーポレーテッド |
キナーゼ調節のための化合物および方法、ならびにその適応
|
|
KR20120112623A
(ko)
|
2009-12-23 |
2012-10-11 |
플렉시콘, 인코퍼레이티드 |
키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증
|
|
TWI619713B
(zh)
|
2010-04-21 |
2018-04-01 |
普雷辛肯公司 |
用於激酶調節的化合物和方法及其適應症
|
|
US8642606B2
(en)
|
2010-09-29 |
2014-02-04 |
Plexxikon Inc. |
ZAP-70 active compounds
|
|
MA34948B1
(fr)
|
2011-02-07 |
2014-03-01 |
Plexxikon Inc |
Composes et procedes de modulation de kinase, et leurs indications
|
|
TWI558702B
(zh)
|
2011-02-21 |
2016-11-21 |
普雷辛肯公司 |
醫藥活性物質的固態形式
|
|
EP2709622A4
(en)
|
2011-05-17 |
2015-03-04 |
Plexxikon Inc |
CINEMA MODULATION AND INDICATIONS THEREFOR
|
|
ES2606148T3
(es)
|
2011-11-01 |
2017-03-22 |
Inopharm Limited |
Composición de disgregación oral de agentes antihistamínicos
|
|
US9358235B2
(en)
|
2012-03-19 |
2016-06-07 |
Plexxikon Inc. |
Kinase modulation, and indications therefor
|
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
|
KR20140030505A
(ko)
|
2012-08-31 |
2014-03-12 |
한미약품 주식회사 |
이베살탄 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 약제학적 캡슐 복합제제
|
|
CN104981247A
(zh)
|
2012-09-06 |
2015-10-14 |
普莱希科公司 |
用于激酶调节的化合物和方法及其适应症
|
|
SMT201800230T1
(it)
|
2012-12-21 |
2018-07-17 |
Plexxikon Inc |
Composti e metodi per la modulazione della chinasi e loro indicazioni
|
|
HRP20181392T1
(hr)
|
2013-03-15 |
2018-10-19 |
Plexxikon Inc. |
Heterociklični spojevi i njihova uporaba
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
AU2014274093B2
(en)
|
2013-05-30 |
2018-11-08 |
Plexxikon Inc. |
Compounds for kinase modulation, and indications therefor
|
|
WO2015134536A1
(en)
|
2014-03-04 |
2015-09-11 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
US20160022604A1
(en)
|
2014-07-23 |
2016-01-28 |
Cadila Healthcare Limited |
Directly compressed ospemifene compositions
|
|
WO2016044067A1
(en)
|
2014-09-15 |
2016-03-24 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
US10160755B2
(en)
|
2015-04-08 |
2018-12-25 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
ES2923943T3
(es)
|
2015-05-06 |
2022-10-03 |
Plexxikon Inc |
Síntesis de un compuesto que modula cinasas
|
|
JP6946194B2
(ja)
*
|
2015-05-06 |
2021-10-06 |
プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． |
キナーゼを調節する化合物の固体形態
|
|
CN113893253A
(zh)
|
2015-05-22 |
2022-01-07 |
普莱希科公司 |
用于治疗braf-v600相关的疾病的plx-8394或plx-7904
|
|
TWI658042B
(zh)
|
2015-05-22 |
2019-05-01 |
美商普雷辛肯公司 |
雜環化合物的合成
|
|
WO2016188816A1
(en)
|
2015-05-22 |
2016-12-01 |
Ucb Biopharma Sprl |
Treatment of epilepsy
|
|
WO2017019804A2
(en)
|
2015-07-28 |
2017-02-02 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
EP4071149A3
(en)
|
2015-09-21 |
2023-01-25 |
Opna Immuno Oncology, SA |
Heterocyclic compounds and uses thereof
|
|
CN108368110A
(zh)
|
2015-12-07 |
2018-08-03 |
普莱希科公司 |
用于激酶调节的化合物和方法以及其适应症
|
|
EP3430005B1
(en)
|
2016-03-16 |
2021-12-08 |
Plexxikon Inc. |
Compounds and methods for kinase modulation and indications therefore
|
|
TW201815766A
(zh)
|
2016-09-22 |
2018-05-01 |
美商普雷辛肯公司 |
用於ｉｄｏ及ｔｄｏ調節之化合物及方法以及其適應症
|
|
AU2017395023B2
(en)
|
2016-12-23 |
2022-04-07 |
Plexxikon Inc. |
Compounds and methods for CDK8 modulation and indications therefor
|
|
JP2020511467A
(ja)
|
2017-03-20 |
2020-04-16 |
プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． |
ブロモドメインを阻害する４−（１−（１，１−ジ（ピリジン−２−イル）エチル）−６−（３，５−ジメチルイソオキサゾール−４−イル）−１Ｈ−ピロロ［３，２−ｂ］ピリジン−３−イル）安息香酸の結晶形
|
|
WO2019023198A1
(en)
|
2017-07-25 |
2019-01-31 |
Plexxikon Inc. |
FORMULATION OF A COMPOUND MODULATING KINASES
|